AN OBSERVATIONAL STUDY OF PERIPHERAL NEUROPATHY IN DIABETES PATIENTS ON METFORMIN THERAPY AND THE ROLE OF VITAMIN B-12 SUPPLEMENTATION

HARITHA PASUPULATI; BODDUPALLY SWATHI; SAMEENA TAHSEEN; MOHAMMED SHAHZAIB ANWER; R.SANDHYA; SAMREEN FATHIMA; SYEDA AMARA FATIMA

doi:10.22159/ijpps.2024v16i12.52405

Authors

HARITHA PASUPULATI Department of Pharmacology, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad, https://orcid.org/0000-0002-6121-5502
BODDUPALLY SWATHI Department of Pharm. D, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad
SAMEENA TAHSEEN Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam Hyderabad, https://orcid.org/0009-0003-4732-4678
MOHAMMED SHAHZAIB ANWER Department of Pharm. D, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam Hyderabad,
R.SANDHYA Department of Bio Technology, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad,
SAMREEN FATHIMA Department of Pharm. D, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam Hyderabad,
SYEDA AMARA FATIMA Department of Pharm. D, Bharat School of Pharmacy, Mangalpally, Ibrahimpatnam Hyderabad,

DOI:

https://doi.org/10.22159/ijpps.2024v16i12.52405

Keywords:

Peripheral neuropathy, diabetes, metformin therapy, vitamin B-12 supplementation, vitamin B-12 deficiency, dosage correlation, metformin duration

Abstract

Objective: This study aims to assess the prevalence of peripheral neuropathy in diabetic patients on metformin therapy using the Douleur Neuropathique 4 (DN-4) scale, explore the relationship between long-term metformin use and serum vitamin B-12 levels, and identify how metformin contributes to neuropathy. Additionally, it seeks to raise awareness about the importance of vitamin B-12 monitoring and supplementation for improving patient quality of life.

Methods: An observational study was conducted involving diabetes patients on metformin therapy. Data were collected on patient demographics, clinical characteristics, and vitamin B-12 levels. Peripheral neuropathy was assessed using the DN-4 questionnaire. Correlations between metformin duration, dosage, vitamin B-12 levels, and neuropathy prevalence were analyzed.

Results: The results indicated that the majority of the study population were male (61.2%) and aged 51-60 years (41.8%), with a majority proportion residing in urban areas (74%). A significant finding was that Peripheral neuropathy was prevalent in 44.8% of patients, with 51.5% exhibiting vitamin B-12 deficiency. Furthermore, the study identified a high prevalence of peripheral neuropathy with a significant correlation between longer metformin use and increased neuropathy (r =0.9372), additionally a strong negative correlation between metformin dosage and Vitamin B-12 levels (r=-0.9189) highlighted the risk of deficiency with higher doses.

Conclusion: The study underscores the critical role of monitoring and supplementing vitamin B-12 in diabetes patients on metformin therapy to mitigate peripheral neuropathy. Regular screening and proactive supplementation could potentially reduce neuropathic complications associated with long-term metformin use.

Downloads

Download data is not yet available.

References

American Diabetes Association. Standards of medical care in diabetes--2013. Diabetes Care. 2013 Jan;36(Suppl 1):S11-66.

Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246-58.

Senthilkumar N,Anandhasayanam A, Mohammed Safil K, Shemimol S. A comparative study on the effectiveness of angiotensin converting enzyme inhibitors (ACEIS) and angiotensin receptor blockers (ARBS) in diabetic nephropathy in type 2 diabetes mellitus patients. Int J Pharm PharmSci 2016;8(8):289-92

Wei J, Wei Y, Huang M, Wang P, Jia S. Is metformin a possible treatment for diabetic neuropathy? J Diabetes. 2022;14(10):658-69.

Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938-48.

Chowdary DL, S I. Prevalence and impact of painful diabetic peripheral neuropathy in patients with type 2 diabetes mellitus with low economic status. Asian J Pharm Clin Res. 2018;11(6):377-80.

Shahwan M, Hassan N, Noshi A. Prevalence and risk factors of vitamin B12 deficiency among patients with type II diabetes on metformin: a study from the northern region of United Arab Emirates. Asian J Pharm Clin Res. 2018;11(8):225-29.

de Groot-Kamphuis DM, van Dijk PR, Groenier KH, Houweling ST, Bilo HJ, Kleefstra N. Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Neth J Med. 2013;71(7):386-90.

Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: an association to bear in mind. World J Diabetes. 2021;12(7):916-31.

Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B12 supplementation for treating vitamin B12 deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: a systematic review. Diabetes MetabSyndr. 2022;16(10):102634.

Gupta K, Jain A, Rohatgi A. An observational study of vitamin b12 levels and peripheral neuropathy profile in patients of diabetes mellitus on metformin therapy. Diabetes MetabSyndr. 2018;12(1):51-8.

Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G, Tesfaye S, Kantartzis K. Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13(2):395.

Alharbi TJ, Tourkmani AM, Abdelhay O, Alkhashan HI, Al-Asmari AK, Bin Rsheed AM, Abuhaimed SN, Mohammed N, AlRasheed AN, AlHarbi NG. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One. 2018;13(10):e0204420.

Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. CurrClinPharmacol. 2011;6(4):260-73.

Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019;98(46):e17918.

Ko SH, Ko SH, Ahn YB, Song KH, Han KD, Park YM, Ko SH, Kim HS. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J Korean Med Sci. 2014;29(7):965-72.

Farooq MD, Tak FA, Ara F, Rashid S, Mir IA. Vitamin B12 deficiency and clinical neuropathy with metformin Use in Type 2 Diabetes. J Xenobiot. 2022;12(2):122-30.

Al Quran T, Khader A, Allan H, Al-Momani R, Aqel HT, Alsaleh M, Bataineh Z. Prevalence of vitamin B12 deficiency in type 2 diabetic patients taking metformin, a cross-sectional study in primary healthcare. Front Endocrinol (Lausanne). 2023;14:1226798.

Al Zoubi MS, Al Kreasha R, Aqel S, Saeed A, Al-Qudimat AR, Al-Zoubi RM. Vitamin B12 deficiency in diabetic patients treated with metformin: a narrative review. Ir J Med Sci. 2024;193(4):1827-35.

Yang R, Yu H, Wu J, Chen H, Wang M, Wang S, Qin X, Wu T, Wu Y, Hu Y. Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China. Front Endocrinol (Lausanne). 2023;14:1082720.

Alvarez M, Sierra OR, Saavedra G, Moreno S. Vitamin B12 deficiency and diabetic neuropathy in patients taking metformin: a cross-sectional study. Endocr Connect. 2019;8(10):1324-29.